LJPC
La Jolla Pharmaceutical Company
LJPC
LJPC
Delisted
LJPC was delisted on the 19th of August, 2022.
80 hedge funds and large institutions have $252M invested in La Jolla Pharmaceutical Company in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 24 increasing their positions, 25 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
3% less call options, than puts
Call options by funds: $1.63M | Put options by funds: $1.69M
4% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 25
Holders
80
Holding in Top 10
4
Calls
$1.63M
Puts
$1.69M
Top Buyers
| 1 | +$15.8M | |
| 2 | +$12.1M | |
| 3 | +$9.75M | |
| 4 |
BC
Boxer Capital
San Diego,
California
|
+$5.32M |
| 5 |
VMI
VHCP Management III
New York
|
+$2.3M |
Top Sellers
| 1 | -$10.2M | |
| 2 | -$4.04M | |
| 3 | -$3.09M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$2.41M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.03M |